1887

Abstract

The capacity of herpes simplex virus type 1 (HSV-1) to replicate decreases tremendously when animal cell cultures are exposed to ligands of both the alpha/beta interferon (IFN-/) receptor and IFN- receptor prior to inoculation with low m.o.i.s of HSV-1. However, the available evidence provides no insight into the possible mechanisms by which co-activation of the IFN-/- and IFN--signalling pathways produces this effect. Therefore, it has not been possible to differentiate between whether these observations represent an important model of host immunological suppression of HSV-1 infection or an irrelevant laboratory phenomenon. Therefore, the current study was initiated to determine whether co-activation of the host cell's IFN-/ and IFN- pathways either (i) induced death of HSV-1-infected cells such that virus replication was unable to occur; or (ii) disrupted one or more steps in the process of HSV-1 replication. To this end, multiple steps in HSV-1 infection were compared in populations of Vero cells infected with HSV-1 strain KOS (m.o.i. of 2·5) and exposed to ligands of the IFN-/ receptor, the IFN- receptor or both. The results demonstrated that IFN- and IFN- interact in a synergistic manner to block the efficient synthesis of viral DNA and nucleocapsid formation in HSV-1-infected cells and do so without compromising host-cell viability. It was inferred that IFN-mediated suppression of HSV-1 replication may be a central mechanism by which the host immune system limits the spread of HSV-1 infection .

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.80979-0
2005-09-01
2019-11-14
Loading full text...

Full text loading...

/deliver/fulltext/jgv/86/9/vir862421.html?itemId=/content/journal/jgv/10.1099/vir.0.80979-0&mimeType=html&fmt=ahah

References

  1. Balish, M. J., Abrams, M. E., Pumfery, A. M. & Brandt, C. R. ( 1992; ). Enhanced inhibition of herpes simplex virus type 1 growth in human corneal fibroblasts by combinations of interferon-α and -γ. J Infect Dis 166, 1401–1403.[CrossRef]
    [Google Scholar]
  2. Cerveny, M., Hessefort, S., Yang, K., Cheng, G., Gross, M. & He, B. ( 2003; ). Amino acid substitutions in the effector domain of the γ 134.5 protein of herpes simplex virus 1 have differential effects on viral response to interferon-α. Virology 307, 290–300.[CrossRef]
    [Google Scholar]
  3. Chen, S. H., Oakes, J. E. & Lausch, R. N. ( 1994; ). Synergistic anti-herpes effect of TNF-α and IFN-γ in human corneal epithelial cells compared with that in corneal fibroblasts. Antiviral Res 25, 201–213.[CrossRef]
    [Google Scholar]
  4. DeLuca, N. A. & Schaffer, P. A. ( 1987; ). Activities of herpes simplex virus type 1 (HSV-1) ICP4 genes specifying nonsense peptides. Nucleic Acids Res 15, 4491–4511.[CrossRef]
    [Google Scholar]
  5. DeLuca, N. A., McCarthy, A. M. & Schaffer, P. A. ( 1985; ). Isolation and characterization of deletion mutants of herpes simplex virus type 1 in the gene encoding immediate-early regulatory protein ICP4. J Virol 56, 558–570.
    [Google Scholar]
  6. Desloges, N., Rahaus, M. & Wolff, M. H. ( 2005; ). Role of the protein kinase PKR in the inhibition of varicella-zoster virus replication by beta interferon and gamma interferon. J Gen Virol 86, 1–6.[CrossRef]
    [Google Scholar]
  7. Elion, G. B. ( 1983; ). The biochemistry and mechanism of action of acyclovir. J Antimicrob Chemother 12 (Suppl. B), 9–17.
    [Google Scholar]
  8. Foster, T. P., Rybachuk, G. V., Alvarez, X., Borkhsenious, O. & Kousoulas, K. G. ( 2003; ). Overexpression of gK in gK-transformed cells collapses the Golgi apparatus into the endoplasmic reticulum inhibiting virion egress, glycoprotein transport, and virus-induced cell fusion. Virology 317, 237–252.[CrossRef]
    [Google Scholar]
  9. Foster, T. P., Melancon, J. M., Baines, J. D. & Kousoulas, K. G. ( 2004; ). The herpes simplex virus type 1 UL20 protein modulates membrane fusion events during cytoplasmic virion morphogenesis and virus-induced cell fusion. J Virol 78, 5347–5357.[CrossRef]
    [Google Scholar]
  10. Halford, W. P., Halford, K. J. & Pierce, A. T. ( 2005a; ). Mathematical analysis demonstrates that interferons-β and -γ interact in a multiplicative manner to disrupt herpes simplex virus replication. J Theor Biol 234, 439–454.[CrossRef]
    [Google Scholar]
  11. Halford, W. P., Maender, J. L. & Gebhardt, B. M. ( 2005b; ). Re-evaluating the role of natural killer cells in innate resistance to herpes simplex virus type 1. Virol J (in press).
    [Google Scholar]
  12. Härle, P., Sainz, B., Jr, Carr, D. J. J. & Halford, W. P. ( 2002; ). The immediate-early protein, ICP0, is essential for the resistance of herpes simplex virus to interferon-α/β. Virology 293, 295–304.[CrossRef]
    [Google Scholar]
  13. Hubenthal-Voss, J., Houghten, R. A., Pereira, L. & Roizman, B. ( 1988; ). Mapping of functional and antigenic domains of the α4 protein of herpes simplex virus 1. J Virol 62, 454–462.
    [Google Scholar]
  14. Khanna, K. M., Bonneau, R. H., Kinchington, P. R. & Hendricks, R. L. ( 2003; ). Herpes simplex virus-specific memory CD8+ T cells are selectively activated and retained in latently infected sensory ganglia. Immunity 18, 593–603.[CrossRef]
    [Google Scholar]
  15. Leib, D. A., Machalek, M. A., Williams, B. R. G., Silverman, R. H. & Virgin, H. W. ( 2000; ). Specific phenotypic restoration of an attenuated virus by knockout of a host resistance gene. Proc Natl Acad Sci U S A 97, 6097–6101.[CrossRef]
    [Google Scholar]
  16. Luker, G. D., Prior, J. L., Song, J., Pica, C. M. & Leib, D. A. ( 2003; ). Bioluminescence imaging reveals systemic dissemination of herpes simplex virus type 1 in the absence of interferon receptors. J Virol 77, 11082–11093.[CrossRef]
    [Google Scholar]
  17. Malik, A. K., Martinez, R., Muncy, L., Carmichael, E. P. & Weller, S. K. ( 1992; ). Genetic analysis of the herpes simplex virus type 1 UL9 gene: isolation of a lacZ insertion mutant and expression in eukaryotic cells. Virology 190, 702–715.[CrossRef]
    [Google Scholar]
  18. Mossman, K. L. & Smiley, J. R. ( 2002; ). Herpes simplex virus ICP0 and ICP34.5 counteract distinct interferon-induced barriers to virus replication. J Virol 76, 1995–1998.[CrossRef]
    [Google Scholar]
  19. Mossman, K. L., Saffran, H. A. & Smiley, J. R. ( 2000; ). Herpes simplex virus ICP0 mutants are hypersensitive to interferon. J Virol 74, 2052–2056.[CrossRef]
    [Google Scholar]
  20. Park, S.-Y., Seol, J.-W., Lee, Y.-J. & 9 other authors ( 2004; ). IFN-γ enhances TRAIL-induced apoptosis through IRF-1. Eur J Biochem 271, 4222–4228.[CrossRef]
    [Google Scholar]
  21. Poon, A. P. W., Silverstein, S. J. & Roizman, B. ( 2002; ). An early regulatory function required in a cell type-dependent manner is expressed by the genomic but not the cDNA copy of the herpes simplex virus 1 gene encoding infected cell protein 0. J Virol 76, 9744–9755.[CrossRef]
    [Google Scholar]
  22. Sainz, B., Jr & Halford, W. P. ( 2002; ). Alpha/beta interferon and gamma interferon synergize to inhibit the replication of herpes simplex virus type 1. J Virol 76, 11541–11550.[CrossRef]
    [Google Scholar]
  23. Sainz, B., Jr, Mossel, E. C., Peters, C. J. & Garry, R. F. ( 2004; ). Interferon-beta and interferon-gamma synergistically inhibit the replication of severe acute respiratory syndrome-associated coronavirus (SARS-CoV). Virology 329, 11–17.[CrossRef]
    [Google Scholar]
  24. Sainz, B., Jr, LaMarca, H. L., Garry, R. F. & Morris, C. A. ( 2005; ). Synergistic inhibition of human cytomegalovirus replication by interferon-alpha/beta and interferon-gamma. Virol J 2, 14.[CrossRef]
    [Google Scholar]
  25. Schang, L. M., Phillips, J. & Schaffer, P. A. ( 1998; ). Requirement for cellular cyclin-dependent kinases in herpes simplex virus replication and transcription. J Virol 72, 5626–5637.
    [Google Scholar]
  26. Simmons, A. & Tscharke, D. C. ( 1992; ). Anti-CD8 impairs clearance of herpes simplex virus from the nervous system: implications for the fate of virally infected neurons. J Exp Med 175, 1337–1344.[CrossRef]
    [Google Scholar]
  27. Smith, K. O. ( 1964; ). Relationship between the envelope and the infectivity of herpes simplex virus. Proc Soc Exp Biol Med 115, 814–816.[CrossRef]
    [Google Scholar]
  28. Soboleski, M. R., Oaks, J. & Halford, W. P. ( 2005; ). Green fluorescent protein is a quantitative reporter of gene expression in individual eukaryotic cells. FASEB J 19, 440–442.
    [Google Scholar]
  29. Takaoka, A., Hayakawa, S., Yanai, H. & 8 other authors ( 2003; ). Integration of interferon-α/β signalling to p53 responses in tumour suppression and antiviral defence. Nature 424, 516–523.[CrossRef]
    [Google Scholar]
  30. Tallarida, R. J. ( 2001; ). Drug synergism: its detection and applications. J Pharmacol Exp Ther 298, 865–872.
    [Google Scholar]
  31. Tallarida, R. J., Stone, D. J., Jr & Raffa, R. B. ( 1997; ). Efficient designs for studying synergistic drug combinations. Life Sci 61, PL417–PL425.
    [Google Scholar]
  32. Theil, D., Derfuss, T., Paripovic, I., Herberger, S., Meinl, E., Schueler, O., Strupp, M., Arbusow, V. & Brandt, T. ( 2003; ). Latent herpesvirus infection in human trigeminal ganglia causes chronic immune response. Am J Pathol 163, 2179–2184.[CrossRef]
    [Google Scholar]
  33. Vollstedt, S., Arnold, S., Schwerdel, C., Franchini, M., Alber, G., Di Santo, J. P., Ackermann, M. & Suter, M. ( 2004; ). Interplay between alpha/beta and gamma interferons with B, T, and natural killer cells in the defense against herpes simplex virus type 1. J Virol 78, 3846–3850.[CrossRef]
    [Google Scholar]
  34. Warner, M. S., Geraghty, R. J., Martinez, W. M., Montgomery, R. I., Whitbeck, J. C., Xu, R., Eisenberg, R. J., Cohen, G. H. & Spear, P. G. ( 1998; ). A cell surface protein with herpesvirus entry activity (HveB) confers susceptibility to infection by mutants of herpes simplex virus type 1, herpes simplex virus type 2, and pseudorabies virus. Virology 246, 179–189.[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.80979-0
Loading
/content/journal/jgv/10.1099/vir.0.80979-0
Loading

Data & Media loading...

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error